Publications by the researcher in collaboration with Mª Luz Martínez Chantar (11)

2024

  1. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis

    Metabolism: Clinical and Experimental, Vol. 158

2023

  1. Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis

    Scientific Reports, Vol. 13, Núm. 1

  2. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2018

  1. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

    Cell Death and Disease, Vol. 9, Núm. 10

2014

  1. S-adenosylmethionine levels regulate the schwann cell DNA methylome

    Neuron, Vol. 81, Núm. 5, pp. 1024-1039

2013

  1. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma

    Journal of Molecular Medicine, Vol. 91, Núm. 8, pp. 939-950

2010

  1. Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide

    Hepatology, Vol. 52, Núm. 1, pp. 105-114

  2. Sirtuin 1 regulation of developmental genes during differentiation of stem cells

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 31, pp. 13736-13741

2009

  1. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

    Oncogene, Vol. 28, Núm. 6, pp. 781-791

  2. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect (Oncogene (2009) 28, (781-791) DOI: 10.1038/onc.2008.436)

    Oncogene

2008

  1. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice

    Hepatology, Vol. 47, Núm. 4, pp. 1191-1199